文献速递血栓与止血

包含1692个凝血因子IX基因变异的交互式数据库更新:为B型血友病提供详细见解

An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B.
PubMed 文献 · J Thromb Haemost · 2023-02-12

该研究更新了凝血因子IX(FIX)基因变异数据库,纳入598个新变异和1645例新临床病例,总计1692个F9变异和5358例相关患者。新变异对应461个FIX残基中的406个(88%),其中点变异占比从2013年的73%降至56%,多态性占比从5%升至21%。5358例患者中152例(2.8%)伴有抑制物。

要点

  • 数据库新增598个F9变异和1645例临床病例,总计1692个变异和5358例患者。
  • 点变异占比从2013年的73%降至56%,多态性占比从5%升至21%。
  • 5358例B型血友病患者中152例(2.8%)伴有抑制物,较前增加93例。

核心结论

  • F9变异分布均匀,突变热点很少,大多数变异与FIX蛋白结构的小扰动相关。
  • 更新后的数据库将帮助临床医生和研究人员评估B型血友病患者的治疗。

研究设计与样本

  • 从出版物和在线资源中鉴定新的F9变异,编译至MySQL数据库,并与人类FIXa蛋白结构进行比较。

主要发现

  • 1692个F9变异对应461个FIX残基中的406个(88%),新增覆盖70个残基。
  • 变异类型包括945个独特点变异、281个缺失、352个多态性、63个插入和51个其他类型。
  • 点变异比例从2013年的73%降至56%,多态性比例从5%升至21%。
  • 具有已知表型的成熟蛋白中764个独特轻度严重度变异包括74个(9.7%)定量I型变异和116个(15.2%)以定性为主的II型变异,其余574个变异类型未明确。
  • 5358例患者中152例(2.8%)伴有抑制物,较前增加93例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic variants in coagulation factor IX (FIX) are associated with hemophilia B, a rare bleeding disease. F9 variants are widespread across the gene and were summarized in our FIX variant database introduced in 2013. OBJECTIVES: We aimed to rationalize the molecular basis for 598 new F9 variants and 1645 new clinical cases, totaling 1692 F9 variants and 5358 related patient cases. METHODS: New F9 variants were identified from publications and online resources, and compiled into a MySQL database for comparison with the human FIXa protein structure. RESULTS: The new total of 1692 F9 variants correspond to 406 (88%) of the 461 FIX residues and now include 70 additional residues. They comprise 945 unique point variants, 281 deletions, 352 polymorphisms, 63 insertions, and 51 others. Most FIX variants were point variants, although their proportion (56%) has reduced compared to 2013 (73%); at the same time, the proportion of polymorphisms has increased from 5% to 21%. The 764 unique mild severity variants in the mature protein with known phenotypes include 74 (9.7%) quantitative type I variants and 116 (15.2%) predominantly qualitative type II variants. The remaining 574 variants types are unspecified. Inhibitors are associated with 152 hemophilia B cases out of 5358 patients (2.8%), an increase of 93 from the previous database. CONCLUSION: The even distribution of the F9 variants revealed few mutational hotspots, and most variants were associated with small perturbations in the FIX protein structure. The updated database will assist clinicians and researchers in assessing treatments for patients with hemophilia B.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Xu Z, Spencer HJ, Harris VA, et al. An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B. J Thromb Haemost. 2023. PMID: 36787808. doi:10.1016/j.jtha.2023.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。